Updated: Thursday 29 October 2026
- Sun Pharmaceutical reports its Q2 FY27 results on Friday 30 October 2026.
- The base: net profit of ₹3,125 crore in Q2 FY26.
- Latest reported quarter, Q1 FY27: net profit of ₹2,901 crore, 26.53% higher than a year earlier.
- On its last 2 results, the shares moved −0.53%, −2.47%.
Sun Pharmaceutical Q2 FY27 results date is set for the board meeting on 30 October 2026. The company will release its financial performance for the quarter ended 30 September 2026.
In the same quarter a year earlier, Sun Pharmaceutical reported a net profit of ₹3,125 crore. Its revenue from operations for that period was ₹14,478 crore.
When does Sun Pharmaceutical announce its Q2 FY27 results?
| Board meeting on results | Friday 30 October 2026 |
| Quarter | Q2 FY27 (ended 30 September 2026) |
| Notice filed with the exchange | 14 Oct 2026 |
Sun Pharmaceutical’s reported quarters
| Quarter | Revenue from operations | Profit before tax | Net profit | Net profit margin | |
|---|---|---|---|---|---|
| Q2 FY26 | 14,478 | 4,155 | 3,125 | 21.58% | The quarter these results are set against |
| Q3 FY26 | 15,521 | 4,207 | 3,381 | 21.79% | |
| Q4 FY26 | 14,612 | 3,537 | 2,710 | 18.54% | |
| Q1 FY27 | 15,300 | 4,089 | 2,901 | 18.96% |
In the most recent quarter, Q1 FY27, Sun Pharmaceutical reported a net profit of ₹2,901 crore. This followed revenue from operations of ₹15,300 crore. The net profit margin was 18.96% in Q1 FY27, compared to 21.58% in Q2 FY26.
What to watch in the Sun Pharmaceutical Q2 FY27 results
| Q2 FY26 (base) | Q1 FY27 (latest reported) | Change | |
|---|---|---|---|
| Revenue from operations | 14,478 | 15,300 | +5.67% |
| Net profit | 3,125 | 2,901 | −7.16% |
| Net profit margin | 21.58% | 18.96% | −2.62 pts |
These results will be measured against the base quarter, Q2 FY26. In that period, the company recorded a net profit of ₹3,125 crore and revenue from operations of ₹14,478 crore. The net profit margin stood at 21.58% during that quarter.
- Margin: net profit was 18.96% of revenue in Q1 FY27 and 21.58% in Q2 FY26.
- Revenue from operations: ₹15,300 crore in Q1 FY27, 10.46% higher than a year earlier.
- Share price: on the last 2 results it moved −0.53% (Q1 FY27), −2.47% (Q4 FY26), measured from the last close before the filing to the next close.
This preview uses the company’s own reported figures. It does not carry analyst estimates, so it does not say whether the results will be above or below anyone’s expectation.
How Sun Pharmaceutical shares moved on its earlier results
| Quarter | Results filed | Window | Change |
|---|---|---|---|
| Q1 FY27 | 31 Jul 2026 | 30 Jul 2026 to 31 Jul 2026 | −0.53% |
| Q4 FY26 | 22 May 2026 | 21 May 2026 to 22 May 2026 | −2.47% |
| Last close (Wednesday 28 October 2026) | ₹1,757.50 |
| Over the last month (21 sessions) | −5.11% |
| Over the last three months (63 sessions) | −11.09% |
Sun Pharmaceutical shares fell 0.5% lower on the release of its last results. The share price closed at ₹1,757.50 on 28 October 2026. Over the last month, the stock price has changed by −5.11%, and over three months, it has changed by −11.09%.
Sun Pharmaceutical dividend history
| Ex-dividend date | Per share | Type |
|---|---|---|
| 7 Jul 2026 | ₹5.00 | Final |
Sun Pharmaceutical Q2 FY27 results date: FAQs
When will Sun Pharmaceutical announce its Q2 FY27 results?
Sun Pharmaceutical’s board meets on Friday 30 October 2026 to consider the results for the quarter ended 30 September 2026, according to its notice to the exchange.
What was Sun Pharmaceutical’s net profit in Q2 FY26?
Sun Pharmaceutical reported a net profit of ₹3,125 crore on revenue from operations of ₹14,478 crore in Q2 FY26 (consolidated figures). The Q2 FY27 results will be set against this quarter.
What was Sun Pharmaceutical’s latest reported net profit?
Net profit was ₹2,901 crore in Q1 FY27, 26.53% higher than a year earlier, or 18.96% of revenue.
How did Sun Pharmaceutical shares react to its last results?
Q1 FY27: −0.53%; Q4 FY26: −2.47%. Each is measured from the last close before the results were filed to the next close.
The meeting date is from the company’s notice to the exchange; results are its filings; prices are from the National Stock Exchange. Calculations are by ThePip. For information only; not investment advice.